Pinned
🚨 BIG NEWS: YouthBio received positive FDA INTERACT feedback for our first-in-class Alzheimer's partial reprogramming gene therapy.
This de-risks our path to the clinic — to be the first to bring partial reprogramming to the human brain!
Details here:

















